Publication Immunoprophylaxis of leprosy: current status and future prospects. Sehgal V N, Sardana K. Indian journal of dermatology, venereology and leprology. 2007; 73 (2) : 71-2.
Publication Leprosy elimination campaign and its impending fallout. Bhattacharya S N, Sehgal V N. International journal of dermatology. 2000; 39 (9) : 667-9.
Publication Leprosy in India. Bhattacharya S N, Sehgal V N. Clinics in dermatology. 1999; 17 (2) : 159-70; discussion 105-6.
Publication Relapse (reactivation) in borderline tuberculoid (BT) leprosy. Sehgal V N, Kumar S, Jain S, et al. The Journal of dermatology. 1998; 25 (1) : 63-5.
Publication Multidrug therapeutic challenges in leprosy. Jain S, Sehgal V N. International journal of dermatology. 1997; 36 (7) : 493-6.
Publication Persisters, relapse (reactivation), drug resistance and multidrug therapy (MDT): uniform diagnostic guidelines for leprosy are needed. Sehgal V N, Jain S, Charya S N. The Journal of dermatology. 1996; 23 (12) : 905-7.
Publication In situ characterization of lymphocytic immunophenotypes and interleukin-2 receptors in cutaneous tuberculosis and leprosy--a comparative evaluation. Sehgal V N, Gupta R P, Karmakar S, et al. Clinical and experimental dermatology. 1994; 19 (4) : 312-6.
Publication Clinico-pathological correlation across the leprosy spectrum: relevance in current context. Sehgal V N, Jain S. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1994; 62 (3) : 441-2. Download PDF
Publication Chemoimmunotherapy: its relevance in contemporary context. Sehgal V N, Jain S. International journal of dermatology. 1994; 33 (10) : 753-4.
Publication Indian dermatology. Sehgal V N. International journal of dermatology. 1993; 32 (11) : 838-44.
Publication Leprosy in children: a prospective study. Sehgal V N, Chaudhry A K. International journal of dermatology. 1993; 32 (3) : 194-7.
Publication Evaluation of phenolic glycolipid-I (PGL-I) antibody as a multidrug therapy (MDT) monitor. Prakash K, Sehgal V N, Aggarwal R. The Journal of dermatology. 1993; 20 (1) : 16-20.
Publication Suspicious lesions and their diagnosis. Sehgal V N, Jain S. Indian journal of leprosy. 1993; 65 (1) : 13-22.
Publication Secondary syphilis mimicking borderline (BL) leprosy. Sehgal V N, Lal S, Jain S, et al. The Journal of dermatology. 1993; 20 (2) : 102-4.
Publication In vivo effects of anti-leprosy drugs on the rat peritoneal macrophages and lymphocyte subpopulations. Sahu A, Saha K, Mukherjee A, et al. International journal of immunopharmacology. 1992; 14 (4) : 721-30.
Publication Lymphocyte adenosine deaminase activity (L-ADA) in leprosy, during and after treatment of reactions. Sehgal V N, Bhattacharya S N, Shah Y, et al. Clinical and experimental dermatology. 1992; 17 (1) : 20-3.
Publication Significance of antibodies to phenolic glycolipid-I in leprosy diagnosis. Prakash K, Aggarwal R, Sehgal V N. The Journal of dermatology. 1992; 19 (12) : 953-8.
Publication Anti-leprosy drugs inhibit the complement-mediated solubilization of pre-formed immune complexes in vitro. Kashyap A, Sehgal V N, Sahu A, et al. International journal of immunopharmacology. 1992; 14 (2) : 269-73.
Publication Reconstruction of anti-leprosy drug depleted complement haemolytic activity by addition of zymosan-treated sera (a source of C142) and CratEDTA (a source of C3-C9). Kashyap A, Saha K, Sehgal V N. International journal of immunopharmacology. 1992; 14 (8) : 1409-14.